Related Experiment Video
Updated: Aug 8, 2026
08:08
Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
Published on: February 27, 2015
Analysis of multiple molecular changes in human endocrine tumours
1Department of Microbiology, University of Texas Medical Branch, Galveston 77555.
Surgical Oncology
|June 1, 1994
Summary
Researchers analyzed molecular changes in three human endocrine tumors, finding significant alterations in the BON carcinoid cell line, including N-ras gene mutations. These findings suggest diverse molecular pathways in endocrine tumor development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Endocrine tumors are neoplasms originating from endocrine glands.
- Understanding the molecular underpinnings of endocrine tumor development is crucial for targeted therapies.
Purpose of the Study:
- To investigate the molecular alterations in three distinct human endocrine tumor cell lines: BON (pancreatic carcinoid), SIM (ileal carcinoid), and STAN (pheochromocytoma).
- To identify key genetic and protein expression changes associated with endocrine tumorigenesis.
Main Methods:
- Analysis of gene mutations, mRNA, and protein expression levels.
- Utilized established human endocrine tumor cell lines (BON, SIM, STAN).
- Focused on genes including N-ras, c-myc, cdc2 kinase, TGF-beta 1, p53, retinoblastoma (RB), and mdm2.
Main Results:
- BON cells showed a homozygous N-ras gene mutation at codon 61 with overexpression of N-ras, c-myc, and cdc2 kinase. Decreased levels of TGF-beta 1, p53, and RB were observed.
- BON cells also exhibited increased mdm2 oncogene expression and both truncated and wild-type RB protein.
- SIM and STAN cells displayed increased N-ras and c-myc mRNA levels, with SIM also showing decreased RB mRNA and protein.
Conclusions:
- Multiple molecular changes characterize human endocrine tumors, with BON cells showing the most pronounced alterations.
- The study suggests the existence of different molecular pathways involved in the pathogenesis of endocrine tumors.
- These characterized cell lines serve as valuable in vitro models for further research into endocrine tumor molecular pathology.
